Cannara Biotech Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Cash & Equivalents	21.81	14.36	6.62	4.27	12.11	8.16
Cash & Short-Term Investments	21.81	14.36	6.62	4.27	12.11	8.16
Cash Growth	51.37%	116.91%	55.02%	-64.75%	48.48%	-69.22%
Accounts Receivable	18.52	14.11	13.04	10.59	8.53	2.85
Other Receivables	-	-	-	-	0.09	0.19
Total Trade Receivables	18.52	14.11	13.04	10.59	8.62	3.04
Inventory	55.63	51.33	40.07	33.77	18.98	7.41
Other Current Assets	1.73	2.36	7.74	3.06	1.28	0.71
Total Current Assets	97.69	82.16	67.47	51.7	40.99	19.25
Net Property, Plant & Equipment	92.96	86	84.94	89.44	83.4	71.75
Other Intangible Assets	2.68	-	-	-	-	-
Other Long-Term Assets	1.15	0.49	2.31	0.39	1.22	0.95
Total Assets	194.49	168.65	154.72	141.52	125.62	92.02
Accounts Payable	10.97	11.08	9.84	8.89	9.31	6.26
Short-Term Debt	6.76	6.76	6.26	3	-	-
Current Portion of Long-Term Debt	2.86	6.26	2.97	2.97	1.97	0.3
Current Portion of Leases	0.16	0.28	0.28	0.08	0.22	0.23
Unearned Revenue	0.23	0.13	0.13	0.16	0.05	0.04
Other Current Liabilities	11.6	9.68	7.52	6.09	0.32	-
Total Current Liabilities	32.57	34.2	27	21.18	11.86	6.83
Long-Term Debt	27.2	28.17	38.45	39.64	46.19	20.15
Long-Term Leases	0.02	0.11	0.37	0.1	0.02	0.22
Other Long-Term Liabilities	8.84	3.94	0.94	0.86	0.82	0.71
Total Long-Term Liabilities	36.07	32.23	39.77	40.6	47.02	21.07
Total Liabilities	68.64	66.43	66.77	61.78	58.88	27.91
Common Stock	104.1	89.76	88.52	88.8	83.3	83.21
Additional Paid-in Capital	14.02	12.28	12.33	10.35	9.72	9.41
Accumulated Other Comprehensive Income	-	-	-	-0.07	0.02	0.1
Retained Earnings	7.72	0.18	-12.9	-19.34	-26.3	-28.61
Total Common Shareholders' Equity	125.85	102.22	87.95	79.74	66.74	64.12
Shareholders' Equity	125.85	102.22	87.95	79.74	66.74	64.12
Total Liabilities & Equity	194.49	168.65	154.72	141.52	125.62	92.02
Total Debt	37	41.58	48.33	45.78	48.39	20.89
Net Cash (Debt)	-15.19	-27.22	-41.71	-41.51	-36.28	-12.73
Net Cash Per Share	-0.16	-0.29	-0.46	-0.46	-0.41	-0.17
Book Value	125.85	102.22	87.95	79.74	66.74	64.12
Book Value Per Share	1.30	1.11	0.96	0.89	0.76	0.84
Tangible Book Value	123.16	102.22	87.95	79.74	66.74	64.12
Tangible Book Value Per Share	1.27	1.11	0.96	0.89	0.76	0.84